Ahnak is critical for cardiac Ca(v)1.2 calcium channel function and its beta adrenergic regulation

University of Bristol (2005) J Physiol 567P, C7

Oral Communications: Ahnak is critical for cardiac Ca(v)1.2 calcium channel function and its beta adrenergic regulation

Haase, Hannelore; Alvarez, Julio L; Petzhold, Daria; Doller, Anke; Behlke, Joachim; Regitz-Zagrosek, Vera; Vassort, Guy; Morano, Ingo;

1. Max Delbrueck Center for Molecular Medicine, Berlin, Germany. 2. INSERM U-637, Montpellier, France. 3. University Medicine Charite, Berlin, Germany.

View other abstracts by:


Defective L-type Ca2+ channel (ICaL) regulation is one major cause for contractile dysfunction in the heart. The ICaL is enhanced by sympathetic nervous stimulation: via activation of beta-adrenergic receptors, PKA phosphorylates the α1C(CaV1.2)- and β2-channel subunits and ahnak, an associated 5643-amino acid (aa) protein (Haase et al. 1999). Herein, we examined the role of a naturally occurring, genetic variant I5236T-ahnak on ICaL elicited under whole-cell patch-clamp conditions on ventricular myocytes obtained from humanely killed 3 month old Sprague Dawley rats. On the native cardiomyocytes, intracellular application of 10 μM of the synthetic ahnak peptide carrying the I5236T mutation (GGLPGTGVQGLE) increased ICaL amplitude from 11.9±0.8 to 18.9±1.4 pA/pF (P<0.05; n=18,20) at 0 mV depolarization, slowed the inactivation together with a leftward shift in the current-voltage relationship. Importantly, the mutated I5236T-peptide prevented specifically the further upregulation of ICaL by the beta-adrenoceptor agonist, isoprenaline. Under the same experimental conditions, the respective wild-type peptide did not mimic the isoprenaline effects on ICaL. Equilibrium binding experiments performed with recombinant β2 subunit and the ahnak-C1 fragment (aa 4646-5288) by analytical ultracentrifugation revealed a dissociation constant for the ahnak-C1/β2 subunit complex of 155±31 nM (n=14). The binding affinity between ahnak-C1 and β2 subunit decreased by ~50% following PKA phosphorylation of both protein partners. A similar decrease in ahnak-C1/β2 subunit binding affinity was induced by the presence of 10 μM mutated peptide (but not wild-type peptide) in equilibrium binding assays. Hence, we suggest the ahnak-C1 domain serves as a physiological brake on ICaL. Relief from this inhibition is proposed as a common pathway used by sympathetic signalling and I5236T-ahnak fragments to increase ICaL. This genetic ahnak variant might cause individual differences in ICaL regulation upon physiological challenges or therapeutic interventions.



Where applicable, experiments conform with Society ethical requirements.

Site search

Filter

Content Type